ea0028p171 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012
Bunce Susan
, Sinclair Daivd
, Smith Jamie
Background: Treatment of HIV patients with antiretroviral therapies may confer an increased cardiovascular risk, possibly mediated through metabolic perturbations induced by these therapies. We sought to determine whether large arterial stiffening, an early marker and predictor of cardiovascular disease, occurs in HIV recipients of HAART, and if so the plausible mechanisms involved.Methods: In this case-control analysis, 56 HIV subjects (mean age 46 ...